Transforming science: Cancer gene identification

Current Opinion in Genetics and Development

Volumn 16, Issue 1, 2006, Pages 23-29

  Collier, Lara S ^a   Largaespada, David A ^a  

^a Minnesota Medical School Minneapolis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; NOTCH1 RECEPTOR; PROTEIN P19; PROTEIN PATCHED 2; TRANSCRIPTION FACTOR PITX2;

CANCER GENETICS; CELL TRANSFORMATION; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; EXON; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENETIC SCREENING; MURINE LEUKEMIA VIRUS; MUTAGENESIS; NONHUMAN; ONCOGENE MYC; ONCOGENE SRC; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE; SIMIAN VIRUS 40; SLEEPING BEAUTY TRANSPOSON; TRANSPOSON; TUMOR SUPPRESSOR GENE; VIRUS ONCOGENE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; DNA TRANSPOSABLE ELEMENTS; EXONS; GENE AMPLIFICATION; GENE DELETION; HUMANS; MODELS, GENETIC; MUTAGENS; ONCOGENES; TRANSLOCATION, GENETIC;

MURINE LEUKEMIA VIRUS; SIMIAN VIRUS 40;

EID: 30644481105     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gde.2005.11.001     Document Type: Review

References (56)

1. K.W. Kinzler, and B. Vogelstein Lessons from hereditary colorectal cancer Cell 87 1996 159 170
2. J.S. Boehm, and W.C. Hahn Understanding transformation: progress and gaps Curr Opin Genet Dev 15 2005 13 17
3. P.A. Futreal, L. Coin, M. Marshall, T. Down, T. Hubbard, R. Wooster, N. Rahman, and M.R. Stratton A census of human cancer genes Nat Rev Cancer 4 2004 177 183 The authors present a comprehensive list, based on published results, of well-validated human cancer genes. This review provides a useful current snap-shot of progress in understanding human cancer genetics and can help serve as the basis for future large-scale projects.
4. T. O'Hare, A.S. Corbin, and B.J. Druker Targeted CML therapy: controlling drug resistance, seeking cure Curr Opin Genet Dev 16 2006 92 99
5. M.J. Mauro, and B.J. Druker STI571: targeting BCR-ABL as therapy for CML Oncologist 6 2001 233 238
6. E. Bier Drosophila, the golden bug, emerges as a tool for human genetics Nat Rev Genet 6 2005 9 23
7. S. Berghmans, C. Jette, D. Langenau, K. Hsu, R. Stewart, T. Look, and J.P. Kanki Making waves in cancer research: new models in the zebrafish Biotechniques 39 2005 227 237
8. G. van Haaften, R.H. Plasterk, and M. Tijsterman Genomic instability and cancer: scanning the Caenorhabditis elegans genome for tumor suppressors Oncogene 23 2004 8366 8375
9. D. Stehelin, H.E. Varmus, J.M. Bishop, and P.K. Vogt DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA Nature 260 1976 170 173
10. D. Muriaux, and A. Rein Encapsidation and transduction of cellular genes by retroviruses Front Biosci 8 2003 d135 d142
11. C.C. O'Shea DNA tumor viruses - the spies who lyse us Curr Opin Genet Dev 15 2005 18 26
12. D.P. Lane, and L.V. Crawford T antigen is bound to a host protein in SV40-transformed cells Nature 278 1979 261 263
13. D.I. Linzer, and A.J. Levine Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells Cell 17 1979 43 52
14. R. Callahan, and G.H. Smith MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways Oncogene 19 2000 992 1001
15. M. van Lohuizen, and A. Berns Tumorigenesis by slow-transforming retroviruses - an update Biochim Biophys Acta 1032 1990 213 235
16. K. Akagi, T. Suzuki, R.M. Stephens, N.A. Jenkins, and N.G. Copeland RTCGD: retroviral tagged cancer gene database Nucleic Acids Res 32 2004 D523 D527 The authors describe a useful web-accessible database, and the software used to create it, of proviral insertion sites from most of the recent large-scale retroviral mutagenesis projects designed to discover leukemia and lymphoma genes. Useful features include the ability to correlate specific common insertion sites with tumor lineage (e.g. B- versus T-cell), and to determine if specific common insertion sites are found together in the same tumor, thereby indicating possible cooperation in oncogenesis.
17. T. Nakamura, D.A. Largaespada, J.D. Shaughnessy Jr., N.A. Jenkins, and N.G. Copeland Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias Nat Genet 12 1996 149 153
18. Y. Du, S.E. Spence, N.A. Jenkins, and N.G. Copeland Cooperating cancer gene identification via oncogenic-retrovirus-induced insertional mutagenesis Blood 106 2005 2498 2505
19. T. Suzuki, H. Shen, K. Akagi, H.C. Morse, J.D. Malley, D.Q. Naiman, N.A. Jenkins, and N.G. Copeland New genes involved in cancer identified by retroviral tagging Nat Genet 32 2002 166 174
20. A.H. Lund, G. Turner, A. Trubetskoy, E. Verhoeven, E. Wientjens, D. Hulsman, R. Russell, R.A. DePinho, J. Lenz, and M. van Lohuizen Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice Nat Genet 32 2002 160 165
21. H. Mikkers, J. Allen, P. Knipscheer, L. Romeijn, A. Hart, E. Vink, and A. Berns High-throughput retroviral tagging to identify components of specific signaling pathways in cancer Nat Genet 32 2002 153 159
22. F.K. Johansson, J. Brodd, C. Eklof, M. Ferletta, G. Hesselager, C.F. Tiger, L. Uhrbom, and B. Westermark Identification of candidate cancer-causing genes in mouse brain tumors by retroviral tagging Proc Natl Acad Sci USA 101 2004 11334 11337
23. P. Pajer, V. Pecenka, V. Karafiat, J. Kralova, Z. Horejsi, and M. Dvorak The twist gene is a common target of retroviral integration and transcriptional deregulation in experimental nephroblastoma Oncogene 22 2003 665 673
24. X. Wu, Y. Li, B. Crise, and S.M. Burgess Transcription start regions in the human genome are favored targets for MLV integration Science 300 2003 1749 1751
25. Arf-/- mice, enabling the discovery of candidate genes involved in sarcomagenesis.
26. A.J. Dupuy, K. Akagi, D.A. Largaespada, N.G. Copeland, and N.A. Jenkins Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system Nature 436 2005 221 226 One of two recent studies demonstrating that a DNA-based transposon system, based on the Sleeping Beauty transposon, can be useful for forward genetic screens for cancer genes. This study shows that SB can initiate lymphoma and medulloblastoma in otherwise wild type mice. Several candidate lymphoma genes, and cancer gene interactions, are described.
27. Z. Ivics, P.B. Hackett, R.H. Plasterk, and Z. Izsvak Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells Cell 91 1997 501 510
28. T. Kamijo, S. Bodner, E. van de Kamp, D.H. Randle, and C.J. Sherr Tumor spectrum in ARF-deficient mice Cancer Res 59 1999 2217 2222
29. E. Santos, S.R. Tronick, S.A. Aaronson, S. Pulciani, and M. Barbacid T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes Nature 298 1982 343 347
30. C.J. Tabin, S.M. Bradley, C.I. Bargmann, R.A. Weinberg, A.G. Papageorge, E.M. Scolnick, R. Dhar, D.R. Lowy, and E.H. Chang Mechanism of activation of a human oncogene Nature 300 1982 143 149
31. K. Berns, E.M. Hijmans, J. Mullenders, T.R. Brummelkamp, A. Velds, M. Heimerikx, R.M. Kerkhoven, M. Madiredjo, W. Nijkamp, and B. Weigelt A large-scale RNAi screen in human cells identifies new components of the p53 pathway Nature 428 2004 431 437 This study demonstrates the power of saturation RNAi screens to identify components of specific, cancer-relevant, signal transduction pathways in cultured mammalian cell lines.
32. P.J. Paddison, J.M. Silva, D.S. Conklin, M. Schlabach, M. Li, S. Aruleba, V. Balija, A. O'Shaughnessy, L. Gnoj, and K. Scobie A resource for large-scale RNA-interference-based screens in mammals Nature 428 2004 427 431 This study demonstrates the feasibility of saturation RNAi screens in cultured mammalian cell lines using large shRNA libraries - one constructed for mouse genes and another for human genes - in a variety of expression vectors. The human shRNA library was used to identify components of the proteasome pathway as a proof-of-principle experiment.
33. I.G. Kolfschoten, B. van Leeuwen, K. Berns, J. Mullenders, R.L. Beijersbergen, R. Bernards, P.M. Voorhoeve, and R. Agami A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity Cell 121 2005 849 858 This study demonstrates the use of an RNAi screen to identify components of specific, cancer-relevant, signal transduction pathways - in this case RAS signaling - to identify genes with tumor suppression activity.
34. T.F. Westbrook, E.S. Martin, M.R. Schlabach, Y. Leng, A.C. Liang, B. Feng, J.J. Zhao, T.M. Roberts, G. Mandel, and G.J. Hannon A genetic screen for candidate tumor suppressors identifies REST Cell 121 2005 837 848 This study demonstrates the use of an RNAi screen to identify genes with tumor suppression activity in human mammary epithelial cells. Candidates were then screened for mutation in human cancer, and one candidate, REST, was found to be mutated in human colorectal cancer.
35. H. Davies, G.R. Bignell, C. Cox, P. Stephens, S. Edkins, S. Clegg, J. Teague, H. Woffendin, M.J. Garnett, and W. Bottomley Mutations of the BRAF gene in human cancer Nature 417 2002 949 954
36. P. Stephens, C. Hunter, G. Bignell, S. Edkins, H. Davies, J. Teague, C. Stevens, S. O'Meara, R. Smith, and A. Parker Lung cancer: intragenic ERBB2 kinase mutations in tumours Nature 431 2004 525 526 This study describes a large-scale exon-re-sequencing project, focused on the ERBB2 kinase gene (also known as HER2 or NEU), in primary human lung cancer. Four percent of these tumors harbored activating mutations, demonstrating the power of this approach to identify rare subsets of patients with mutations in genes encoding proteins that could be pharmacologically targeted.
37. P. Stephens, S. Edkins, H. Davies, C. Greenman, C. Cox, C. Hunter, G. Bignell, J. Teague, R. Smith, and C. Stevens A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer Nat Genet 37 2005 590 592 This study describes a large-scale exon-re-sequencing project using human primary breast cancer specimens and cell lines. The coding exons and splice sites of the entire set of human kinases was re-sequenced. Cell lines have more changes than do primary tumor cells. Many mutations were discovered that must be very rare in breast cancer, and strong evidence for a background of non-selected variation during tumorigenesis was found. This work has implications for expected results in other similar projects, and it reports the discovery of a possible new mutator phenotype in human breast cancer.
38. T.L. Wang, C. Rago, N. Silliman, J. Ptak, S. Markowitz, J.K. Willson, G. Parmigiani, K.W. Kinzler, B. Vogelstein, and V.E. Velculescu Prevalence of somatic alterations in the colorectal cancer cell genome Proc Natl Acad Sci USA 99 2002 3076 3080
39. A. Bardelli, D.W. Parsons, N. Silliman, J. Ptak, S. Szabo, S. Saha, S. Markowitz, J.K. Willson, G. Parmigiani, and K.W. Kinzler Mutational analysis of the tyrosine kinome in colorectal cancers Science 300 2003 949
40. Z. Wang, D. Shen, D.W. Parsons, A. Bardelli, J. Sager, S. Szabo, J. Ptak, N. Silliman, B.A. Peters, and M.S. van der Heijden Mutational analysis of the tyrosine phosphatome in colorectal cancers Science 304 2004 1164 1166
41. S. Bamford, E. Dawson, S. Forbes, J. Clements, R. Pettett, A. Dogan, A. Flanagan, J. Teague, P.A. Futreal, and M.R. Stratton The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website Br J Cancer 91 2004 355 358 The authors present a comprehensive list of all somatic mutations detected in human cancer - regardless of determination of functional significance. This catalogue is relevant for future large-scale exon-re-sequencing projects because it can provide estimates of the neutral substitution rates that might be encountered in such projects and indicates the possibility that genetic heterogeneity might be found in human cancer.
42. T.H. Rabbitts Chromosomal translocations in human cancer Nature 372 1994 143 149
43. A. Kallioniemi, O.P. Kallioniemi, D. Sudar, D. Rutovitz, J.W. Gray, F. Waldman, and D. Pinkel Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors Science 258 1992 818 821
44. J.R. Pollack, C.M. Perou, A.A. Alizadeh, M.B. Eisen, A. Pergamenschikov, C.F. Williams, S.S. Jeffrey, D. Botstein, and P.O. Brown Genome-wide analysis of DNA copy-number changes using cDNA microarrays Nat Genet 23 1999 41 46
45. D. Pinkel, R. Segraves, D. Sudar, S. Clark, I. Poole, D. Kowbel, C. Collins, W.L. Kuo, C. Chen, and Y. Zhai High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays Nat Genet 20 1998 207 211
46. R. Lucito, J. West, A. Reiner, J. Alexander, D. Esposito, B. Mishra, S. Powers, L. Norton, and M. Wigler Detecting gene copy number fluctuations in tumor cells by microarray analysis of genomic representations Genome Res 10 2000 1726 1736
47. R. Lucito, J. Healy, J. Alexander, A. Reiner, D. Esposito, M. Chi, L. Rodgers, A. Brady, J. Sebat, and J. Troge Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation Genome Res 13 2003 2291 2305
48. T.L. Wang, C. Maierhofer, M.R. Speicher, C. Lengauer, B. Vogelstein, K.W. Kinzler, and V.E. Velculescu Digital karyotyping Proc Natl Acad Sci USA 99 2002 16156 16161
49. T.L. Wang, L.A. Diaz Jr., K. Romans, A. Bardelli, S. Saha, G. Galizia, M. Choti, R. Donehower, G. Parmigiani, and M. Shih Ie Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients Proc Natl Acad Sci USA 101 2004 3089 3094
50. I.e.M. Shih, and T.L. Wang Apply innovative technologies to explore cancer genome Curr Opin Oncol 17 2005 33 38
51. X. Zhou, N.P. Rao, S.W. Cole, S.C. Mok, Z. Chen, and D.T. Wong Progress in concurrent analysis of loss of heterozygosity and comparative genomic hybridization utilizing high density single nucleotide polymorphism arrays Cancer Genet Cytogenet 159 2005 53 57
52. D.G. Wang, J.B. Fan, C.J. Siao, A. Berno, P. Young, R. Sapolsky, G. Ghandour, N. Perkins, E. Winchester, and J. Spencer Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome Science 280 1998 1077 1082
53. M. Lin, L.J. Wei, W.R. Sellers, M. Lieberfarb, W.H. Wong, and C. Li dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data Bioinformatics 20 2004 1233 1240
54. L.A. Garraway, H.R. Widlund, M.A. Rubin, G. Getz, A.J. Berger, S. Ramaswamy, R. Beroukhim, D.A. Milner, S.R. Granter, and J. Du Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma Nature 436 2005 117 122 This study describes the analysis of NCI60 cell lines, using single nucleotide polymorphism arrays to detect loss-of-heterozygosity events and genome copy number changes. When these data were combined with expression microarray analysis, a transcription factor called MITF was found to be consistently amplified and overexpressed in a subset of human melanoma. Experiments were done to verify a role for MITF in melanoma development and maintenance. MITF is a master regulator of melanocyte specification, but on the basis of these results is also a lineage-specific oncogene.
55. G. Bignell, R. Smith, C. Hunter, P. Stephens, H. Davies, C. Greenman, J. Teague, A. Butler, S. Edkins, and C. Stevens Sequence analysis of the protein kinase gene family in human testicular germ-cell tumors of adolescents and adults Genes Chromosomes Cancer 45 2005 42 46 The authors describe the results of re-sequencing the kinase gene family in testicular cancer. The results indicate that for some cancers somatic mutations in this family of genes are very rare.
56. H. Davies, C. Hunter, R. Smith, P. Stephens, C. Greenman, G. Bignell, J. Teague, A. Butler, S. Edkins, and C. Stevens Somatic mutations of the protein kinase gene family in human lung cancer Cancer Res 65 2005 7591 7595 The authors describe the results of re-sequencing the kinase gene family in lung cancer. The results indicate that for some lung cancers somatic mutations in this family of genes are common. However, most detected mutations are likely to be 'bystander' mutations. Although some of the mutated kinases might be driving lung cancer, each one is infrequent.